SERPINA3 (aka alpha-1-antichymotrypsin)

Frontiers in Bioscience

Volumn 12, Issue 8, 2007, Pages 2821-2835

  Baker, Crystal ^a   Belbin, Olivia ^a   Kalsheker, Noor ^a   Morgan, Kevin ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

ACT gene; Alpha 1 antichymotrypsin; Alzheimer's disease; Nervous system; Review; Serpin; Single nucleotide polymorphism; SNP

Indexed keywords

SERINE PROTEINASE INHIBITOR; SERPINA3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; SERPINS; VARIATION (GENETICS);

EID: 34347229750     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2275     Document Type: Review

References (103)

1. Mucke, L., G. Q. Yu, L. McConlogue, E. M. Rockenstein, C. R. Abraham & E. Masliah: Astroglial expression of human alpha (1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice. Am J Pathol, 157, 2003-10 (2000)
2. Nilsson, L. N., K. R. Bales, G. DiCarlo, M. N. Gordon, D. Morgan, S. M. Paul & H. Potter: Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. J Neurosci, 21, 1444-51 (2001) (Pubitemid 32182186)
3. Baker, C., H. M. Nielsen, L. Minthon, H. T. Wright, S. Chappell, J. Okyere, S. May, K. Morgan, N. Kalsheker & S. M. Janciauskiene: Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression. Neurobiol Aging (2005)
4. Morgan, K., F. Licastro, L. Tilley, A. Ritchie, L. Morgan, S. Pedrini & N. Kalsheker: Polymorphism in the alpha (1)-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations. Human Genetics, 109, 303-310 (2001) (Pubitemid 32926925)
5. Silverman, G. A., P. I. Bird, R. W. Carrell, F. C. Church, P. B. Coughlin, P. G. Gettins, J. A. Irving, D. A. Lomas, C. J. Luke, R. W. Moyer, P. A. Pemberton, E. Remold-O'Donnell, G. S. Salvesen, J. Travis & J. C. Whisstock: The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem, 276, 33293-6 (2001)
6. Irving, J. A., R. N. Pike, A. M. Lesk & J. C. Whisstock: Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res, 10, 1845-64 (2000) (Pubitemid 32049132)
7. Chandra, T., R. Stackhouse, V. J. Kidd, K. J. Robson & S. L. Woo: Sequence homology between human alpha 1-antichymotrypsin, alpha 1-antitrypsin, and antithrombin III. Biochemistry, 22, 5055-61 (1983) (Pubitemid 14249336)
8. Hwang, S. R., B. Steineckert, A. Kohn, M. Palkovits & V. Y. Hook: Molecular studies define the primary structure of alpha1-antichymotrypsin (ACT) protease inhibitor in Alzheimer's disease brains. Comparison of act in hippocampus and liver. J Biol Chem, 274, 1821-7 (1999)
9. Potempa, J., E. Korzus & J. Travis: The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem, 269, 15957-60 (1994) (Pubitemid 24209273)
10. Huber, R. & R. W. Carrell: Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry, 28, 8951-66 (1989) (Pubitemid 19283457)
11. Janciauskiene, S.: Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys Acta, 1535, 221-35 (2001) (Pubitemid 32241132)
12. Morii, M. & J. Travis: Amino acid sequence at the reactive site of human alpha 1-antichymotrypsin. J Biol Chem, 258, 12749-52 (1983)
13. Mast, A. E., J. J. Enghild & G. Salvesen: Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis. Biochemistry, 31, 2720-8 (1992)
14. Plotnick, M. I., H. Rubin & N. M. Schechter: The effects of reactive site location on the inhibitory properties of the serpin alpha (1)-antichymotrypsin. J Biol Chem, 277, 29927-35 (2002)
15. Huntington, J. A., R. J. Read & R. W. Carrell: Structure of a serpin-protease complex shows inhibition by deformation. Nature, 407, 923-6 (2000)
16. Hopkins, P. C., R. W. Carrell & S. R. Stone: Effects of mutations in the hinge region of serpins. Biochemistry, 32, 7650-7 (1993) (Pubitemid 23240808)
17. Whisstock, J. C., R. Skinner, R. W. Carrell & A. M. Lesk: Conformational changes in serpins: I. The native and cleaved conformations of alpha (1)-antitrypsin. J Mol Biol, 296, 685-99 (2000)
18. Gooptu, B., B. Hazes, W. S. Chang, T. R. Dafforn, R. W. Carrell, R. J. Read & D. A. Lomas: Inactive conformation of the serpin alpha (1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci U S A, 97, 67-72 (2000) (Pubitemid 30055785)
19. Mast, A. E., J. J. Enghild, S. V. Pizzo & G. Salvesen: Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry, 30, 1723-30 (1991)
20. Pizzo, S. V., A. E. Mast, S. R. Feldman & G. Salvesen: In vivo catabolism of alpha 1-antichymotrypsin is mediated by the Serpin receptor which binds alpha 1-proteinase inhibitor, antithrombin III and heparin cofactor II. Biochim Biophys Acta, 967, 158-62 (1988) (Pubitemid 18265671)
21. Perlmutter, D. H., J. Travis & P. I. Punsal: Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency. J Clin Invest, 81, 1774-80 (1988)
22. Horvath, A. J., J. A. Irving, J. Rossjohn, R. H. Law, S. P. Bottomley, N. S. Quinsey, R. N. Pike, P. B. Coughlin & J. C. Whisstock: The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins. J Biol Chem, 280, 43168-78 (2005) (Pubitemid 43049283)
23. Baumann, U., R. Huber, W. Bode, D. Grosse, M. Lesjak & C. B. Laurell: Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins. J Mol Biol, 218, 595-606 (1991) (Pubitemid 121003963)
24. Elliott, P. R., X. Y. Pei, T. R. Dafforn & D. A. Lomas: Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci, 9, 1274-81 (2000) (Pubitemid 30602280)
25. Poller, W., J. P. Faber, S. Weidinger, K. Tief, S. Scholz, M. Fischer, K. Olek, M. Kirchgesser & H. H. Heidtmann: A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics, 17, 740-3 (1993) (Pubitemid 23282831)
26. Travis, J., J. Bowen & R. Baugh: Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases. Biochemistry, 17, 5651-6 (1978) (Pubitemid 9084432)
27. Christensson, A., C. B. Laurell & H. Lilja: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem, 194, 755-63 (1990)
28. Frenette, G., D. Deperthes, R. R. Tremblay, C. Lazure & J. Y. Dube: Purification of enzymatically active kallikrein hK2 from human seminal plasma. Biochim Biophys Acta, 1334, 109-15 (1997) (Pubitemid 27063953)
29. Hakansson, H. O. & K. Ohlsson: Interactions in vitro and in vivo between human and porcine cationic pancreatic elastase and plasma protease inhibitors. Biol Chem Hoppe Seyler, 369, 309-15 (1988)
30. Beatty, K., J. Bieth & J. Travis: Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem, 255, 3931-4 (1980)
31. Wiedow, O. & U. Meyer-Hoffert: Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med, 257, 319-28 (2005) (Pubitemid 40461184)
32. Aronsen, K. F., G. Ekelund, C. O. Kindmark & C. B. Laurell: Sequential changes of plasma proteins after surgical trauma. Scand J Clin Lab Invest Suppl, 124, 127-36 (1972)
33. Naidoo, N., B. S. Cooperman, Z. M. Wang, X. Z. Liu & H. Rubin: Identification of lysines within alpha 1-antichymotrypsin important for DNA binding. An unusual combination of DNA-binding elements. J Biol Chem, 270, 14548-55 (1995)
34. Yanai, I., H. Benjamin, M. Shmoish, V. Chalifa-Caspi, M. Shklar, R. Ophir, A. Bar-Even, S. Horn-Saban, M. Safran, E. Domany, D. Lancet & O. Shmueli: Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics, 21, 650-9 (2005) (Pubitemid 40424791)
35. Gopalan, S., A. Kasza, W. Xu, D. L. Kiss, K. M. Wilczynska, R. E. Rydel & T. Kordula: Astrocyte-and hepatocyte-specific expression of genes from the distal serpin subcluster at 14q32.1 associates with tissue-specific chromatin structures. J Neurochem, 94, 763-73 (2005) (Pubitemid 41098508)
36. Namciu, S. J., R. D. Friedman, M. D. Marsden, L. M. Sarausad, C. L. Jasoni & R. E. Fournier: Sequence organization and matrix attachment regions of the human serine protease inhibitor gene cluster at 14q32.1. Mamm Genome, 15, 162-78 (2004) (Pubitemid 38293808)
37. Bao, J. J., R. N. Sifers, V. J. Kidd, F. D. Ledley & S. L. Woo: Molecular evolution of serpins: homologous structure of the human alpha 1-antichymotrypsin and alpha 1-antitrypsin genes. Biochemistry, 26, 7755-9 (1987) (Pubitemid 18009295)
38. Kalsheker, N., S. Morley & K. Morgan: Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans, 30, 93-8 (2002)
39. Lim, L., H. Zhou & R. H. Costa: The winged helix transcription factor HFH-4 is expressed during choroid plexus epithelial development in the mouse embryo. Proc Natl Acad Sci U S A, 94, 3094-9 (1997) (Pubitemid 27157269)
40. Kordula, T., M. Bugno, R. E. Rydel & J. Travis: Mechanism of interleukin-1-and tumor necrosis factor alpha-dependent regulation of the alpha 1-antichymotrypsin gene in human astrocytes. J Neurosci, 20, 7510-6 (2000)
41. Gopalan, S. M., K. M. Wilczynska, B. S. Konik, L. Bryan & T. Kordula: Astrocyte-specific expression of the alpha1-antichymotrypsin and glial fibrillary acidic protein genes requires activator protein-1. J Biol Chem, 281, 1956-63 (2006) (Pubitemid 43845781)
42. Gopalan, S. M., K. M. Wilczynska, B. S. Konik, L. Bryan & T. Kordula: Nuclear factor-1-X regulates astrocyte-specific expression of the alpha1-antichymotrypsin and glial fibrillary acidic protein genes. J Biol Chem, 281, 13126-33 (2006) (Pubitemid 43855223)
43. Castell, J. V., M. J. Gomez-Lechon, M. David, T. Andus, T. Geiger, R. Trullenque, R. Fabra & P. C. Heinrich: Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett, 242, 237-9 (1989) (Pubitemid 19020112)
44. Cichy, J., J. Potempa, R. K. Chawla & J. Travis: Regulation of alpha 1-antichymotrypsin synthesis in cells of epithelial origin. FEBS Lett, 359, 262-6 (1995)
45. Kordula, T., R. E. Rydel, E. F. Brigham, F. Horn, P. C. Heinrich & J. Travis: Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem, 273, 4112-8 (1998) (Pubitemid 28103279)
46. Pak, S. C., V. Kumar, C. Tsu, C. J. Luke, Y. S. Askew, D. J. Askew, D. R. Mills, D. Bromme & G. A. Silverman: SRP-2 is a cross-class inhibitor that participates in postembryonic development of the nematode Caenorhabditis elegans: initial characterization of the clade L serpins. J Biol Chem, 279, 15448-59 (2004) (Pubitemid 38618945)
47. Lomas, D. A. & R. W. Carrell: Serpinopathies and the conformational dementias. Nat Rev Genet, 3, 759-68 (2002)
48. Tachikawa, H., M. Tsuda, K. Onoe, M. Ueno, S. Takagi & Y. Shinohara: alpha-1-Antichymotrypsin gene A1252G variant (ACT Isehara-1) is associated with a lacunar type of ischemic cerebrovascular disease. J Hum Genet, 46, 45-7 (2001) (Pubitemid 32178926)
49. Takada, S., M. Tsuda, S. Fujinami, M. Yamamura, T. Mitomi & T. Katsunuma: Incorporation of alpha-1-antichymotrypsin into carcinoma cell nuclei of human stomach adenocarcinoma transplanted into nude mice. Cancer Res, 46, 3688-91 (1986) (Pubitemid 16096930)
50. Takada, S., M. Tsuda, M. Matsumoto, S. Fujinami, M. Yamamura & T. Katsunuma: Incorporation of alpha-1-antichymotrypsin into human stomach adenocarcinoma cell nuclei and inhibition of DNA primase activity. Tokai J Exp Clin Med, 13, 321-7 (1988) (Pubitemid 20218223)
51. Koomen, J. M., L. N. Shih, K. R. Coombes, D. Li, L. C. Xiao, I. J. Fidler, J. L. Abbruzzese & R. Kobayashi: Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin Cancer Res, 11, 1110-8 (2005) (Pubitemid 40175760)
52. Allgayer, H., R. Babic, K. U. Grutzner, B. C. Beyer, A. Tarabichi, F. W. Schildberg & M. M. Heiss: Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns. Clin Exp Metastasis, 16, 62-73 (1998) (Pubitemid 28122556)
53. Higashiyama, M., O. Doi, H. Yokouchi, K. Kodama, S. Nakamori & R. Tateishi: Alpha-1-antichymotrypsin expression in lung adenocarcinoma and its possible association with tumor progression. Cancer, 76, 1368-76 (1995)
54. Leinonen, J., T. Lovgren, T. Vornanen & U. H. Stenman: Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha 1-antichymotrypsin. Clin Chem, 39, 2098-103 (1993) (Pubitemid 23306157)
55. Martinez, M., F. Espana, M. Royo, J. M. Alapont, S. Navarro, A. Estelles, J. Aznar, C. D. Vera & J. F. Jimenez-Cruz: The proportion of prostate-specific antigen (PSA) complexed to alpha (1)-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 microg/L. Clin Chem, 48, 1251-6 (2002) (Pubitemid 34809833)
56. Ishibashi, M.: Standardization of prostate-specific antigen (PSA) assays: can interchangeability of PSA measurements be improved? Clin Chem, 52, 1-2 (2006) (Pubitemid 43032459)
57. Yamamura, J., Y. Miyoshi, Y. Tamaki, T. Taguchi, K. Iwao, M. Monden, K. Kato & S. Noguchi: mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers. Cancer Sci, 95, 887-92 (2004) (Pubitemid 40045523)
58. Eriksson, S., B. Lindmark & H. Lilja: Familial alpha 1-antichymotrypsin deficiency. Acta Med Scand, 220, 447-53 (1986)
59. Sandford, A. J., T. Chagani, T. D. Weir & P. D. Pare: Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease. Dis Markers, 13, 257-60 (1998) (Pubitemid 28115990)
60. Mahadeva, R., L. Sharples, R. I. Ross-Russell, A. K. Webb, D. Bilton & D. A. Lomas: Association of alpha (1) - antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis. Thorax, 56, 53-8 (2001) (Pubitemid 32041720)
61. Haass, C.: Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. Embo J, 23, 483-8 (2004) (Pubitemid 38282380)
62. Scheuner, D., C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T. D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe & S. Younkin: Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med, 2, 864-70 (1996) (Pubitemid 26296755)
63. Kienlen-Campard, P. & J. N. Octave: Correlation between beta-amyloid peptide production and human APP-induced neuronal death. Peptides, 23, 1199-204 (2002) (Pubitemid 34786699)
64. Abraham, C. R., D. J. Selkoe & H. Potter: Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell, 52, 487-501 (1988) (Pubitemid 18067514)
65. Fraser, P. E., J. T. Nguyen, D. R. McLachlan, C. R. Abraham & D. A. Kirschner: Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro. J Neurochem, 61, 298-305 (1993) (Pubitemid 23175914)
66. Sun, Y. X., H. T. Wright & S. Janciauskiene: Alpha1-antichymotrypsin/ Alzheimer's peptide Abeta (1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells. J Neurosci Res, 67, 511-22 (2002) (Pubitemid 34117121)
67. Janciauskiene, S., H. Rubin, C. M. Lukacs & H. T. Wright: Alzheimer's peptide Abeta1-42 binds to two betasheets of alpha1-antichymotrypsin and transforms it from inhibitor to substrate. J Biol Chem, 273, 28360-4 (1998) (Pubitemid 28496138)
68. Evans, K. C., E. P. Berger, C. G. Cho, K. H. Weisgraber & P. T. Lansbury, Jr.: Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci U S A, 92, 763-7 (1995)
69. Sun, Y. X., H. T. Wright & S. Janciauskiene: Glioma cell activation by Alzheimer's peptide Abeta1-42, alpha1-antichymotrypsin, and their mixture. Cell Mol Life Sci, 59, 1734-43 (2002) (Pubitemid 35346977)
70. Nilsson, L. N. G., G. W. Arendash, R. E. Leighty, D. A. Costa, M. A. Low, M. F. Garcia, J. R. Cracciolo, A. Rojiani, X. Wu, K. R. Bales, S. M. Paul & H. Potter: Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiology of Aging, In Press, Corrected Proof, (2004)
71. Kamboh, M. I., D. K. Sanghera, R. E. Ferrell & S. T. DeKosky: APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat Genet, 10, 486-8 (1995)
72. Nilsson, L. N., S. Das & H. Potter: Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha (1)-antichymotrypsin in astrocytes: significance for Alzheimer's disease. Neurochem Int, 39, 361-70 (2001) (Pubitemid 32907400)
73. Talbot, C., H. Houlden, N. Craddock, R. Crook, M. Hutton, C. Lendon, G. Prihar, J. C. Morris, J. Hardy & A. Goate: Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. Neuroreport, 7, 534-6 (1996) (Pubitemid 26105035)
74. Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines & M. A. Pericak-Vance: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-3 (1993) (Pubitemid 23275809)
75. Haines, J. L., M. L. Pritchard, A. M. Saunders, J. M. Schildkraut, J. H. Growdon, P. C. Gaskell, L. A. Farrer, S. A. Auerbach, J. F. Gusella, P. A. Locke, B. L. Rosi, L. Yamaoka, G. W. Small, P. M. Conneally, A. D. Roses & M. A. Pericak-Vance: No genetic effect of alpha1-antichymotrypsin in Alzheimer disease. Genomics, 33, 53-6 (1996) (Pubitemid 26119394)
76. Itabashi, S., H. Arai, T. Matsui, S. Matsushita, T. Muramatsu, S. Higuchi, J. Q. Trojanowski & H. Sasaki: Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases. Exp Neurol, 151, 237-40 (1998) (Pubitemid 28285904)
77. Lamb, H., J. Christie, A. B. Singleton, A. Leake, R. H. Perry, P. G. Ince, I. G. McKeith, L. M. Melton, J. A. Edwardson & C. M. Morris: Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases. Neurology, 50, 388-91 (1998)
78. Murphy, G. M., Jr., E. V. Sullivan, D. Gallagher-Thompson, L. W. Thompson, C. M. van Duijn, L. S. Forno, W. G. Ellis, W. J. Jagust, J. Yesavage & J. R. Tinklenberg: No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease. Neurology, 48, 1313-6 (1997) (Pubitemid 27240555)
79. Thome, J., A. Baumer, J. Kornhuber, M. Rosler & P. Riederer: Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome. J Neural Transm Park Dis Dement Sect, 10, 207-12 (1995) (Pubitemid 26013324)
80. Yoshiiwa, A., K. Kamino, H. Yamamoto, T. Kobayashi, M. Imagawa, Y. Nonomura, H. Yoneda, T. Sakai, Y. Nishiwaki, N. Sato, H. Rakugi, T. Miki & T. Ogihara: alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers. Ann Neurol, 42, 115-7 (1997) (Pubitemid 27304788)
81. Munoz, E., V. Obach, R. Oliva, M. J. Marti, M. Ezquerra, P. Pastor, F. Ballesta & E. Tolosa: Alpha1-antichymotrypsin gene polymorphism and susceptibility to Parkinson's disease. Neurology, 52, 297-301 (1999) (Pubitemid 29059055)
82. Licastro, F., S. Pedrini, C. Ferri, V. Casadei, M. Govoni, A. Pession, F. L. Sciacca, F. Veglia, G. Annoni, M. Bonafe, F. Olivieri, C. Franceschi & L. M. Grimaldi: Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol, 48, 388-91 (2000)
83. Licastro, F., M. Chiappelli, L. M. Grimaldi, K. Morgan, N. Kalsheker, E. Calabrese, A. Ritchie, E. Porcellini, G. Salani, M. Franceschi & N. Canal: A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease. Neurobiol Aging, 26, 449-53 (2005) (Pubitemid 40093928)
84. Ritchie, A., K. Morgan & N. Kalsheker: Allele-specific overexpression in astrocytes of an Alzheimer's disease associated alpha-1-antichymotrypsin promoter polymorphism. Brain Res Mol Brain Res, 131, 88-92 (2004) (Pubitemid 39458281)
85. Morgan, K., L. Morgan, K. Carpenter, J. Lowe, L. Lam, S. Cave, J. Xuereb, C. Wischik, C. Harrington & N. A. Kalsheker: Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease. Hum Genet, 99, 27-31 (1997) (Pubitemid 26419849)
86. Ishii, T., T. Matsuse, S. Teramoto, H. Matsui, T. Hosoi, Y. Fukuchi & Y. Ouchi: Association between alpha-1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease. Eur J Clin Invest, 30, 543-8 (2000) (Pubitemid 30330469)
87. Benetazzo, M. G., L. S. Gile, C. Bombieri, G. Malerba, M. Massobrio, P. F. Pignatti & M. Luisetti: alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. Respir Med, 93, 648-54 (1999) (Pubitemid 29476255)
88. Chappell, S., L. Daly, K. Morgan, T. Guetta Baranes, J. Roca, R. Rabinovich, A. Millar, S. C. Donnelly, V. Keatings, W. MacNee, J. Stolk, P. Hiemstra, M. Miniati, S. Monti, C. M. O'Connor & N. Kalsheker: Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat, 27, 103-9 (2006) (Pubitemid 43042972)
89. Yamamoto, M., I. Kondo, N. Ogawa, M. Asanuma, Y. Yamashita & Y. Mizuno: Genetic association between susceptibility to Parkinson's disease and alpha1-antichymotrypsin polymorphism. Brain Res, 759, 153-5 (1997) (Pubitemid 27286355)
90. Furiya, Y., M. Hirano, N. Kurumatani, T. Nakamuro, R. Matsumura, N. Futamura & S. Ueno: Alpha-1-antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA). Brain Res Mol Brain Res, 138, 178-81 (2005) (Pubitemid 41138036)
91. Obach, V., M. Revilla, N. Vila, A. A. Cervera & A. A. Chamorro: alpha (1)-antichymotrypsin polymorphism: a risk factor for hemorrhagic stroke in normotensive subjects. Stroke, 32, 2588-91 (2001) (Pubitemid 33055311)
92. Vila, N., V. Obach, M. Revilla, R. Oliva & A. Chamorro: Alpha (1)-antichymotrypsin gene polymorphism in patients with stroke. Stroke, 31, 2103-5 (2000)
93. Klimkowicz, A., A. Slowik, T. Dziedzic, R. Polczyk & A. Szczudlik: Post-stroke dementia is associated with alpha (1)-antichymotrypsin polymorphism. J Neurol Sci, 234, 31-6 (2005) (Pubitemid 40910340)
94. Tang, G., H. Xie, L. Xu, Y. Hao, D. Lin & D. Ren: Genetic study of Apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet, 114, 446-9 (2002) (Pubitemid 34525244)
95. Wang, Y. C., H. C. Liu, T. Y. Liu, C. J. Hong & S. J. Tsai: Genetic association analysis of alpha-1-antichymotrypsin polymorphism in Parkinson's disease. Eur Neurol, 45, 254-6 (2001)
96. Lin, J. J., K. C. Yueh, C. Y. Chang, C. H. Chen & S. Z. Lin: The homozygote AA genotype of the alpha1-antichymotrypsin gene may confer protection against earlyonset Parkinson's disease in women. Parkinsonism Relat Disord, 10, 469-73 (2004) (Pubitemid 39487194)
97. Grasbon-Frodl, E. M., R. Egensperger, S. Kosel, R. Kruger, O. Riess, P. Mehraein & M. B. Graeber: The alpha1-antichymotrypsin A-allele in German Parkinson disease patients. J Neural Transm, 106, 729-36 (1999) (Pubitemid 29401360)
98. Arpa, A., T. del Ser, G. Goda, R. Barba & B. Bornstein: Apolipoprotein E, angiotensin-converting enzyme and alpha-1-antichymotrypsin genotypes are not associated with post-stroke dementia. J Neurol Sci, 210, 77-82 (2003) (Pubitemid 36539409)
99. Endoh, M., A. Ueki, K. Takahashi, H. Yamanaka, S. Izumi & T. Tabira: Alpha-1-Antichymotrypsin Is Not Associated with the Increased Frequency of Apolipoprotein-E-Epsilon-4 Allele in Elderly Non-Demented Leprosy Patients. Dementia and Geriatric Cognitive Disorders, 9, 26-28 (1998) (Pubitemid 28010654)
100. Ohara, K., Y. Suzuki, K. Yoshida, H. Terada & K. Ohara: Lack of association between alpha1-antichymotrypsin polymorphism and late-onset depressive disorder. Psychiatry Res, 88, 221-6 (1999) (Pubitemid 30074177)
101. Tyrrell, J., M. Cosgrave, J. McPherson, Z. Hawi, V. Trulock, J. Calvert, B. Lawlor & M. Gill: Presenilin 1 and alpha-1-antichymotrypsin polymorphisms in Down syndrome: no effect on the presence of dementia. Am J Med Genet, 88, 616-20 (1999)
102. Nacmias, B., A. Tedde, B. M. Guarnieri, C. Petruzzi, L. Ortenzi, A. Serio, L. Amaducci & S. Sorbi: Analysis of apolipoprotein E, alpha1-antichymotrypsin and presenilin-1 genes polymorphisms in dementia caused by normal pressure hydrocephalus in man. Neurosci Lett, 229, 177-80 (1997) (Pubitemid 27316075)
103. Salvatore, M., A. C. Seeber, B. Nacmias, R. Petraroli, S. Sorbi & M. Pocchiari: Alpha1 antichymotrypsin signal peptide polymorphism in sporadic Creutzfeldt-Jakob disease. Neurosci Lett, 227, 140-2 (1997) (Pubitemid 27245054)